» Articles » PMID: 17872445

Anti-inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

Abstract

Antibodies play a central role in immunity by forming an interface with the innate immune system and, typically, mediate proinflammatory activity. We describe a novel posttranslational modification that leads to anti-inflammatory activity of antibodies of immunoglobulin G, isotype 4 (IgG4). IgG4 antibodies are dynamic molecules that exchange Fab arms by swapping a heavy chain and attached light chain (half-molecule) with a heavy-light chain pair from another molecule, which results in bispecific antibodies. Mutagenesis studies revealed that the third constant domain is critical for this activity. The impact of IgG4 Fab arm exchange was confirmed in vivo in a rhesus monkey model with experimental autoimmune myasthenia gravis. IgG4 Fab arm exchange is suggested to be an important biological mechanism that provides the basis for the anti-inflammatory activity attributed to IgG4 antibodies.

Citing Articles

Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant.

Aurelia L, Purcell R, Theisen R, Kelly A, Esterbauer R, Ramanathan P Sci Adv. 2025; 11(9):eads1482.

PMID: 40009690 PMC: 11864192. DOI: 10.1126/sciadv.ads1482.


Type 2 immunity in allergic diseases.

Ogulur I, Mitamura Y, Yazici D, Pat Y, Ardicli S, Li M Cell Mol Immunol. 2025; 22(3):211-242.

PMID: 39962262 PMC: 11868591. DOI: 10.1038/s41423-025-01261-2.


Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models.

Lim J, Jensen S, Plomp J, Vankerckhoven B, Kneip C, Coppejans R iScience. 2025; 28(2):111684.

PMID: 39898046 PMC: 11783450. DOI: 10.1016/j.isci.2024.111684.


Roles of immunoglobulin GM and KM allotypes and Fcγ receptor 2 A genotypes in humoral immunity to a conserved microbial polysaccharide in pulmonary diseases.

Pandey J, Nietert P, Namboodiri A, Kimball C, Flume P Genes Immun. 2025; .

PMID: 39774260 DOI: 10.1038/s41435-024-00318-y.


The molecular reach of antibodies crucially underpins their viral neutralisation capacity.

Huhn A, Nissley D, Wilson D, Kutuzov M, Donat R, Tan T Nat Commun. 2025; 16(1):338.

PMID: 39746910 PMC: 11695720. DOI: 10.1038/s41467-024-54916-5.